Condition: Methamphetamine Abuse · Methamphetamine-dependence · Addiction, Substance · Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
The goal of this clinical trial is to learn if administering a high dose stimulant with Contingency Management reduces days of use in adults who use methamphetamine better than the usual treatment provided by the clinic. The main questions the trial aims to answer are: Is a high dose stimulant better than a placebo and usual treatment at helping reduce the number of days they use methamphetamine? Is a high dose stimulant with contingency management better than placebo and usual treatment at helping people reduce the number of days they use methamphetamine? Participants will be placed randomly into one of four groups: 1. Usual treatment and placebo 2. Usual treatment, placebo and contingency management 3. Usual treatment and high dose stimulant 4. Usual treatment, high dose stimulant and contingency management Participation includes the following: 1. Participants will receive medication or placebo weekly for 15 weeks. 2. Participants will attend the clinic for weekly treatment 3. Participants will attend the clinic once every 2 weeks for study visits. Each visit will take about an hour to complete. At these visits, participants will be asked to provide a urine sample and complete questionnaires.
This description comes directly from the study's public registry record.
Devon Blanchette · 780-953-6630 · dblanchette@changemark.ca
Amina Sow · 438 860 2452 · amina.sow.chum@ssss.gouv.qc.ca
Always discuss trial participation with your own doctor first.
| Rapid Access Addiction Medicine Clinic, St. Paul's Hospital | Vancouver, British Columbia, Canada | Recruiting |
| River Stone Recovery Centre | Fredericton, New Brunswick, Canada | Suspended |
| Center for Addiction and Mental Health | Toronto, Ontario, Canada | Recruiting |
| University of Montreal Hospital Research Center | Montreal, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05854667